The maximum treatment period in our study was 2 years, and its expected that these drugs will be used for much longer in real-world settings, especially considering the high likeliness of weight regain once you discontinue treatment. She underlined the significant public health concern that is obesity, with prevalence rates continuing to rise globally. For a while, we were limited to lifestyle interventions, diet and exercise, which have been shown time and time again to not be sufficient for sustained weight loss in this patient population, she said
Theres also an order set for treatment and a standardized note template that reminds providers what questions to ask
Insulin Production and Calorie Usage Semaglutide helps your body produce more insulin
This article examines the current evidence, potential risks, and the importance of evidence-based treatment decisions in rheumatoid arthritis management
In March 2025, Eli Lilly announced plans to launch its blockbuster diabetes and weight-loss drug, Mounjaro (tirzepatide), in lucrative markets like Brazil, India, and Mexico in the second half of 2025